B. Gombe

Setting Up a Standardized Peripheral Blood Mononuclear Cells Processing Laboratory to Support Multi-center HIV/AIDS Vaccine and Intervention Trials

A. Kamali, P. Kaleebu, J. Birungi, 2011 .

Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus–Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy

P. Kaleebu, H. Grosskurth, J. Kyosiimire-Lugemwa, 2019, The Journal of infectious diseases.

Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial

P. Kaleebu, J. Weber, Sarah Joseph, 2022, PloS one.

Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens

P. Kaleebu, O. J. Sande, F. Kibengo, 2023, Frontiers in Immunology.

Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy

P. Kaleebu, M. Musenero, J. Serwanga, 2023, Frontiers in Immunology.

Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda

P. Kaleebu, M. Cotten, M. Musenero, 2023, Frontiers in Immunology.

A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences

P. Kaleebu, R. Shattock, Sarah Joseph, 2023, Human vaccines & immunotherapeutics.